Buyer landscape
Likely buyers · Pharma.
Prepared 2026-08-28 with GP Intel · deterministic scoring, published weights: gp-intel.com/methodology/league-tables
How companies like this sold · 1,473 verified exits: 26% to sponsors, 62% to corporates and platforms, 11% via IPO, 1% other routes. Route shift since 2020: sponsors 23% (was 30%), corporates and platforms 67% (was 54%), IPO 8% (was 15%).
The list: 25 Tier 1 · 0 Tier 2 of 120 matched buyers. A first round of the Tier 1 names plus the expansion buyers covers the demonstrated demand.
Financial buyers · 25
Tier 1 · Very High · score 70+
1. ARCHIMED and Institut Mérieux SponsorVery High86
54 platform investments in Healthcare · 19 deals 2024–26
AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M
18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.
Backed IRAB, 2026 · Pharma, Spain
2. ArchiMed SponsorVery High85
56 platform investments in Healthcare · 18 deals 2024–26
AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M
18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.
Backed IRAB, 2026 · Pharma, Spain
3. Archimedes Partners SponsorVery High85
53 platform investments in Healthcare · 21 deals 2024–26
AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M
18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.
Backed IRAB, 2026 · Pharma, Spain
4. ArchiMed and Tethys Invest SponsorVery High85
54 platform investments in Healthcare · 18 deals 2024–26
AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M
18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.
Backed IRAB, 2026 · Pharma, Spain
5. Bpifrance Investissement SponsorVery High83
10 platform investments in Healthcare · 35 deals 2024–26
AUM €57.3B · Bpifrance Amorçage Industriel · 2023 vintage · deploying · check €1-8M
Accelerating: 30 deals in the last 2 years vs 4.5/yr before.
Backed Biogaran, 2026 · Pharma, France
6. Merieux Equity Partners / Vitruvian Partners SponsorVery High80
57 platform investments in Healthcare · 6 deals 2024–26
AUM €1.6B · Mérieux Participations 5 · 2026 vintage · deploying · check €7-50M
2 platform investments since the 2026 vintage · early in deployment vs its usual 8 per fund.
Backed CEVA Santé Animale, 2025 · Pharma, France
7. SHS Gesellschaft für Beteiligungsmanagement SponsorVery High80
37 platform investments in Healthcare · 6 deals 2024–26
SHS VI · 2022 vintage · partially deployed · check €5-41M
12 platform investments since the 2022 vintage · largely deployed vs its usual 8 per fund.
Backed AMW, 2026 · Pharma, Germany
8. BC Partners SponsorVery High79
19 platform investments in Healthcare · 5 deals 2024–26
AUM €40.0B · BC Partners XII · 2025 vintage · deploying · check €44-330M
5 platform investments since the 2025 vintage · early in deployment vs its usual 12 per fund.
Backed InfoRLife, 2026 · Pharma, Switzerland
9. capiton VI SponsorVery High79
13 platform investments in Healthcare · 3 deals 2024–26
AUM €1.6B · capiton Quantum · 2023 vintage · deploying · check €5-37M
4 platform investments since the 2023 vintage · mid-deployment vs its usual 7 per fund.
Bought Dec Group from capiton, 2025 · Pharma, Switzerland
10. BC Partners / PSP Investments / Ontario Teachers SponsorVery High79
13 platform investments in Healthcare · 5 deals 2024–26
AUM €40.0B · BC Partners XII · 2025 vintage · deploying · check €44-330M
5 platform investments since the 2025 vintage · early in deployment vs its usual 12 per fund.
Backed InfoRLife, 2026 · Pharma, Switzerland
11. BC Partners + Intermediate Capital Group SponsorVery High79
13 platform investments in Healthcare · 5 deals 2024–26
AUM €40.0B · BC Partners XII · 2025 vintage · deploying · check €44-330M
5 platform investments since the 2025 vintage · early in deployment vs its usual 12 per fund.
Backed InfoRLife, 2026 · Pharma, Switzerland
12. BC Partners and AXA Private Equity SponsorVery High79
14 platform investments in Healthcare · 5 deals 2024–26
AUM €40.0B · BC Partners XII · 2025 vintage · deploying · check €44-330M
5 platform investments since the 2025 vintage · early in deployment vs its usual 12 per fund.
Backed InfoRLife, 2026 · Pharma, Switzerland
13. BC Partners Fund XI and CPP Investments SponsorVery High79
13 platform investments in Healthcare · 5 deals 2024–26
AUM €40.0B · BC Partners XII · 2025 vintage · deploying · check €44-330M
5 platform investments since the 2025 vintage · early in deployment vs its usual 12 per fund.
Backed InfoRLife, 2026 · Pharma, Switzerland
14. NORD Holding SponsorVery High79
15 platform investments in Healthcare · 15 deals 2024–26
AUM €5.0B · NORD Holding all inclusive Fitness Continuation Fund · 2026 vintage · deploying
Accelerating: 13 deals in the last 2 years vs 2.5/yr before.
Backed NEC MED PHARMA GmbH, 2016 · Pharma, Germany
15. Inflexion SponsorVery High78
10 platform investments in Healthcare · 27 deals 2024–26
AUM €11.0B · Inflexion Buyout Fund VII · 2026 vintage · deploying · check €90-675M
4 platform investments since the 2026 vintage · mid-deployment vs its usual 6 per fund.
Bought Primed from Paragon Partners, 2026 · MedTech, Germany
16. NORD Holding / Pinova Capital SponsorVery High78
12 platform investments in Healthcare · 12 deals 2024–26
AUM €5.0B · NORD Holding all inclusive Fitness Continuation Fund · 2026 vintage · deploying
Accelerating: 10 deals in the last 2 years vs 2.5/yr before.
Backed NEC MED PHARMA GmbH, 2016 · Pharma, Germany
17. Armira SponsorVery High78
6 platform investments in Healthcare · 12 deals 2024–26
AUM €5.0B · Armira III · 2025 vintage · deploying · check €20-150M
8 platform investments since the 2025 vintage · mid-deployment vs its usual 10 per fund.
Backed almapharm, 2024 · Pharma, Germany
18. Turenne Groupe SponsorVery High76
55 platform investments in Healthcare · 34 deals 2024–26
AUM €2.0B · Capital Sante 3 · 2025 vintage · deploying · check €3-21M
20 platform investments since the 2025 vintage · early in deployment vs its usual 80 per fund.
Backed Destia, 2026 · Healthcare, France
19. Idia SponsorVery High76
12 platform investments in Healthcare · 27 deals 2024–26
AUM €2.4B · Crédit Agricole Assurances Avenir et Territoires · 2026 vintage · deploying · check €2-15M
5 platform investments since the 2026 vintage · early in deployment vs its usual 25 per fund.
Backed DELPHARM, 2024 · Pharma, France
20. Ring Capital SponsorVery High76
10 platform investments in Healthcare · 32 deals 2024–26
AUM €470M · Ring Altitude II · 2025 vintage · deploying · check €4-33M
17 platform investments since the 2025 vintage · largely deployed vs its usual 13 per fund.
Backed Dermascan, 2026 · HealthTech, France
21. Charterhouse Capital Partners SponsorVery High76
11 platform investments in Healthcare · 10 deals 2024–26
AUM €7.0B · Charterhouse Capital Partners XI · 2023 vintage · deploying · check €28-210M
10 platform investments since the 2023 vintage · mid-deployment vs its usual 14 per fund.
Backed Labomar, 2023 · Pharma, Italy
22. Lauxera Capital Partners SponsorVery High76
16 platform investments in Healthcare · 6 deals 2024–26
AUM €780M · Lauxera Growth II · 2025 vintage · deploying · check €10-78M
3 platform investments since the 2025 vintage · early in deployment vs its usual 8 per fund.
Backed Bridge to Life, 2026 · MedTech, US
23. IK Partners SponsorVery High75
34 platform investments in Healthcare · 52 deals 2024–26
AUM €13.8B · IK Partnership Fund III · 2025 vintage · deploying · check €10-75M
18 platform investments since the 2025 vintage · largely deployed vs its usual 13 per fund.
Backed Ceva Santé Animale, 2003 · Pharma, France
24. Bridgepoint SponsorVery High75
34 platform investments in Healthcare · 43 deals 2024–26
AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M
4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.
Bought PharmaZell from Maxburg Capital Partners, 2020 · Pharma, Germany
25. Bridgepoint Development Capital SponsorVery High75
31 platform investments in Healthcare · 36 deals 2024–26
AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M
4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.
Backed PharmaZell, 2020 · Pharma, Germany
Scores and facts derive from verified deal records only; sample floors and thresholds are published on the methodology page. Figures marked with a tilde are bands, not disclosures.